MSU prof breaks ground with childhood cancer discovery

Today the drug is in clinical trials in 24 U.S. hospitals. Patient trials are aimed at assessing the drug's effectiveness against neuroblastoma. If successful, it could help raise the survival rate for children battling an often unforgiving disease.

Read more here: http://www.lansingstatejournal.com/story/news/local/2016/01/07/msu-prof-breaks-ground-childhood-cancer-discovery/75520838/